We speculate that the more aggressive course of renal failure in patients with SMARCAL1-associated disease relative to podocin deficiency—which exclusively affects the podocyte—may be related to additional functional effects of defective SMARCAL1 expressed in other nephron structures. The gene discussed is NPHS2; the disease is kidney failure.